FindTrial
Sign In

Plants use in the management of viral respiratory infections, as in COVID-19

Ethnopharmacological strategy in the management of viral respiratory infections, as in COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8g6f2rv
Enrollment
Unknown
Registered
2022-01-27
Start date
2021-02-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infections

Interventions

The total of 240 participants, 120 in each group, placebo and agent.The number of shots (twice daily) and the duration of treatment (14 days) follow the regimen in clinical studies that evaluated the
D20.215.784.844
56229

Sponsors

Universidade Federal do Rio Grande do Sul
Lead Sponsor
Universidade Federal do Rio Grande do Sul
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Older than 18 years; suspected coronavirus infection

Exclusion criteria

Exclusion criteria: Hospital internment; intolerance to the tested compounds; unwillingness to use teas daily; pregnant women or women of reproductive age who do not use hormonal contraceptives.

Design outcomes

Primary

MeasureTime frame
Reduction in the number of days of symptoms such as cough, dyspnea and headache, assessed by questionnaire and daily follow-up. Data collected on the first day of tea drinking and throughout the 14 days daily.—

Secondary

MeasureTime frame
50% reduction in cough days, measured through daily questionnaires over the 14 days of intervention—

Countries

Brazil

Contacts

Public ContactCaroline Dani
carolinedani@yahoo.com.br+55(051)993436505

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 3, 2026